You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tarceva

Showing 1 - 25 of 482
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

EGFR Positive NSCLC Trial in Goyang-Si (Erlotinib plus Bevacizumab, Erlotinib)

Active, not recruiting
  • EGFR Positive Non-small Cell Lung Cancer
  • Goyang-Si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)

Active, not recruiting
Has Results
  • Brain and Central Nervous System Tumors
  • Induction Chemotherapy
  • +3 more
  • Palo Alto, California
  • +5 more
Nov 29, 2022

Liver Cancer Trial in Houston (Bevacizumab, Erlotinib)

Completed
Has Results
  • Liver Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 3, 2022

NSCLC, Brain Cancer Trial in Tucson, Houston (Tarceva (Erlotinib HCl), Radiation Therapy)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Brain Cancer
  • Tarceva (Erlotinib hydrochloride)
  • Radiation Therapy
  • Tucson, Arizona
  • +1 more
Sep 14, 2021

Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)

Active, not recruiting
  • Adult Solid Neoplasm
  • Erlotinib Hydrochloride
  • Irinotecan Hydrochloride
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Lung Cancer Trial in New Haven, Houston (Erlotinib, AZD6244, MK-2206)

Completed
Has Results
  • Lung Cancer
  • New Haven, Connecticut
  • +1 more
Dec 14, 2021

Cancer Trial in Oslo, Trondheim (Erlotinib, Radiation)

Terminated
  • Cancer
  • Oslo, International/Other, Norway
  • +1 more
Mar 25, 2021

Lung Cancer, Non Small Cell Lung Cancer (NSCLC), Breast Cancer Trial in Sarasota, Oklahoma City, Nashville (entinostat,

Completed
  • Lung Cancer
  • +3 more
  • Sarasota, Florida
  • +2 more
Nov 11, 2021

Lung Cancer Trial in Houston (DOTAP:Chol-TUSC2, Erlotinib, Dexamethasone)

Terminated
  • Lung Cancer
  • Houston, Texas
    UT MD Anderson Cancer Center
Feb 11, 2022

Non-small Cell Lung Carcinoma Trial (Pembrolizumab, Paclitaxel, Carboplatin)

Completed
Has Results
  • Non-small Cell Lung Carcinoma
  • Pembrolizumab
  • +7 more
  • (no location specified)
Oct 13, 2022

NSCLC Trial in Badalona, Málaga (Docetaxel, Cisplatin, Gemcitabine)

Completed
  • Non-small Cell Lung Cancer
  • Badalona, Barcelona, Spain
  • +1 more
Jun 8, 2022

Cancer, Tumors, Tumors Trial in Denmark (Alectinib, Atezolizumab, Avelumab)

Recruiting
  • Cancer
  • +3 more
  • Aalborg, Denmark
  • +6 more
Oct 25, 2022

Carcinoma, Non-Small Cell Lung, EGFR Gene Mutation Trial in Changsha (Gemcitabine platinum combined with erlotinib)

Recruiting
  • Carcinoma, Non-Small Cell Lung
  • EGFR Gene Mutation
  • Gemcitabine platinum combined with erlotinib
  • Changsha, Hunan, China
    Hunan Province Tumor Hospital
Feb 28, 2022

NSCLC Trial in New Haven, Farmington (KD019, Erlotinib)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • New Haven, Connecticut
  • +1 more
May 9, 2022

NSCLC Trial in United States (Erlotinib + Sorafenib, Erlotinib + Placebo)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Erlotinib + Sorafenib
  • Erlotinib + Placebo
  • Fort Myers, Florida
  • +15 more
Feb 15, 2022

NSCLC Trial in United States (bevacizumab, Erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Galloway, New Jersey
  • +6 more
Jun 17, 2022

Lung Tumor Trial in São Paulo (Alectinib, Pembrolizumab, Nivolumab)

Active, not recruiting
  • Lung Neoplasm
  • São Paulo, Brazil
    Hospital Municipal Vila Santa Catarina
Oct 5, 2021

NSCLC Trial in Denmark (Tarceva, Radiotherapy)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Tarceva
  • Radiotherapy
  • Aarhus, Denmark
  • +6 more
Nov 4, 2020

NSCLC Trial in United States (bevacizumab, erlotinib HCl, )

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Vallejo, California
  • +3 more
Dec 18, 2020

Cirrhosis, Hepatocellular Carcinoma Trial in United States (Erlotinib, Erlotinib Hydrochloride, Laboratory Biomarker Analysis)

Active, not recruiting
Has Results
  • Cirrhosis
  • Hepatocellular Carcinoma
  • Jacksonville, Florida
  • +5 more
Feb 24, 2022

NSCLC Trial in United States (erlotinib, bemcentinib)

Completed
  • Non-Small Cell Lung Cancer
  • Los Angeles, California
  • +9 more
Aug 16, 2022

Head Neck Cancer Trial in Houston (drug, other, behavioral)

Active, not recruiting
  • Head and Neck Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 31, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 15, 2021

Esophageal Cancer Trial in United States (Erlotinib, Bevacizumab, Paclitaxel)

Completed
Has Results
  • Esophageal Cancer
  • Fort Myers, Florida
  • +8 more
Feb 18, 2022

Locally Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Amsterdam (gemcitabine, erlotinib, metformin)

Completed
  • Locally Advanced Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Amsterdam, Netherlands
    Academic Medical Center
Apr 19, 2021